Early Prosthetic Joint Infection (PJI) represents one of the most fearsome complications of joint replacement. No international consensus has been reached regarding the best approach for early prosthetic knee and hip infections. The aim of this updated systematic review is to assess whether DAIR is an effective choice of treatment in early post-operative and acute hematogenous PJI. This systematic review was performed using the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The diagnostic criteria defining a PJI, the most present pathogen and the days between the index procedure and the onset of the PJI were extracted from the selected articles. Additionally, mean follow-up, antibiotic regimen and success rate of the treatment were also reported. The articles included provided a cohort of 970 patients. Ten studies specified the joint of their cohort in PJIs regarding either hip prostheses or knee prostheses, resulting in 454 total knees and 460 total hips. The age of the patients ranged from 18 to 92 years. Success rates for the DAIR treatments in the following cohort ranged from 55.5% up to a maximum of 90% (mean value 71%). Even though DAIR procedure is quite limited, it is still considered an effective option for patients developing an early post-operative or acute hematogenous PJI. However, there is a lack of studies, in particular of RCTs, comparing DAIR with one-stage and two-stage revision protocols in the setting of early PJIs, reflecting the necessity to conduct further high-quality studies to face the burden of early PJI.